A-358 - Efficacy, safety and willingness to be retreated with tirbanibulin 1% ointment in patients with actinic keratosis over a field treatment up to 100 cm²
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
A-358 - Efficacy, safety and willingness to be retreated with tirbanibulin 1% ointment in patients with actinic keratosis over a field treatment up to 100 cm². // EJC Skin Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S2772611826003368?dgcid=rss_sd_all
A-358 - Efficacy, safety and willingness to be retreated with tirbanibulin 1% ointment in patients with actinic keratosis over a field treatment up to 100 cm². EJC Skin Cancer. https://www.sciencedirect.com/science/article/pii/S2772611826003368?dgcid=rss_sd_all
“A-358 - Efficacy, safety and willingness to be retreated with tirbanibulin 1% ointment in patients with actinic keratosis over a field treatment up to 100 cm².” EJC Skin Cancer.
@article{article100072,
title = {A-358 - Efficacy, safety and willingness to be retreated with tirbanibulin 1\% ointment in patients with actinic keratosis over a field treatment up to 100 cm²},
journal = {EJC Skin Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S2772611826003368?dgcid=rss_sd_all}
}